Physician profile
Sanjay Kumar Patel
NPI 1326001603
$6,104.22
in general payments reported to CMS, 2019-2025
41 companies · $809 in 2025
The $809 reported for 2025 was more than what a typical Cardiovascular Disease provider received nationally (typical 2025 total: $433).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $1,224 · 2020: $364 · 2021: $926 · 2022: $1,002 · 2023: $886 · 2024: $893 · 2025: $809.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $2,588.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $2,588.17 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abiomed | $921.32 | 2019-2025 | Impella |
| E.R. Squibb & Sons, L.L.C. | $822.86 | 2019-2025 | Camzyos, Eliquis |
| Pfizer INC. | $596.97 | 2019-2025 | |
| Janssen Pharmaceuticals, INC | $529.93 | 2019-2023 | Xarelto |
| Amgen INC. | $384.13 | 2019-2025 | Repatha, Repatha |
| Zoll Services LLC (A/K/A Zoll Lifecor Corp) | $325.33 | 2019-2025 | Lifevest |
| Boehringer Ingelheim Pharmaceuticals, INC. | $273.88 | 2019-2025 | Jardiance |
| Novartis Pharmaceuticals Corporation | $258.62 | 2019-2025 | |
| Shockwave Medical, INC | $239.81 | 2023-2024 | Shockwave Ivl System With The Shockwave C2 Coronary Ivl Catheter, Shockwave Ivl System With The Shockwave C2 Coronary Ivl Catheter |
| Boston Scientific Corporation | $180.99 | 2020-2024 | Watchman Flx |
| Heartflow, INC. | $146.35 | 2023 | Ffrct |
| Astellas Pharma US INC | $133.07 | 2019 | |
| Lexicon Pharmaceuticals, INC. | $122.78 | 2023-2024 | Inpefa |
| Merck Sharp & Dohme LLC | $119.99 | 2021-2025 | Verquvo |
| Astrazeneca Pharmaceuticals LP | $86.61 | 2019-2022 |
Show all 41 companies
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Sanjay Patel listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.